Edding Genor Group Holdings Limited (FRA:67N0)

Germany · Delayed Price · Currency is EUR

0.1780

-0.0080 (-4.30%)

At close: Jun 26, 2026

-33.08% (1Y)

Market Cap	371.19M
Revenue (ttm)	302.90M -2.3%
Net Income	48.62M +2.9%
EPS	0.03 +1.0%
Shares Out	n/a
PE Ratio	7.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1780
Previous Close	0.1860
Day's Range	0.1780 - 0.1780
52-Week Range	0.1670 - 0.5700
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 27, 2026

About FRA:67N0

Edding Genor Group Holdings Limited, together with its subsidiaries, engages in the research, development, manufacturing, and distribution of biopharmaceutical products in China, the United States, and internationally. The company offers GB491, a differentiated CDK4/6 inhibitor for advanced or metastatic breast cancer; GB261, a novel CD3/CD20 bispecific antibody which is in Phase III clinical trial for autoimmune diseases; and GB263T and GB268, tri-specific antibody candidates which are Phase I clinical trial. It also provides Vancocin for mult... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2001

Employees 1,545

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 67N0

Financial Performance

Financial numbers in CNY Financial Statements